New Delhi, May 27 -- Antimicrobial resistance (AMR) is emerging as a significant health threat in low- and middle-income countries (LMICs), accounting for 4.3 million of the five million global AMR-related deaths each year.

Despite this burden, these countries remain heavily dependent on high-income countries (HICs), particularly in the West, for the discovery, development, and access to antibiotics.

Although many LMIC governments have adopted action plans to address AMR, progress has been hindered by the high costs associated with research and clinical trials.

Over the past 80-85 years, antibiotics have revolutionised medicine, transformed public health, and saved millions of lives.

However, we are now entering a post-antibiotic era...